StonvexLoading…
StonvexStonvexStonvexCore line items from RMBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $180.19M | $707.63M | $517.39M | $338.87M |
Operating Income | $61.76M | $260.22M | $189.39M | $126.14M |
Net Income | $59.86M | $230.46M | $166.62M | $118.24M |
EPS (Diluted) | $0.55 | $2.11 | $1.53 | $1.09 |
Total Assets | $1.53B | $1.53B | $1.41B | $1.47B |
Total Liabilities | $139.91M | $165.12M | $117.87M | $239.83M |
Cash & Equivalents | $134.32M | $182.82M | $79.20M | $87.76M |
Free Cash Flow OCF − CapEx | $71.57M | $333.18M | $239.88M | $157.39M |
Shares Outstanding | 108.14M | 107.78M | 107.65M | 107.59M |